147th Meeting of the National Advisory Council on Drug Abuse
Hybrid Meeting – May 7, 2024
Closed Session
This meeting is closed to the public in accordance with the provisions set forth in section 552b{c}(4) and 552b{c}(6), Title 5, U.S. Code and section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).
Time | Presentation |
---|---|
10:30 a.m. | Call to Order Nora Volkow, M.D. Director, NIDA Review of Policy and Procedures Susan Weiss, Ph.D. Executive Secretary National Advisory Council on Drug Abuse Director, Division of Extramural Research, NIDA |
10:45 a.m. | Council Review of Grant Applications Division of Epidemiology, Services, and Prevention Research (DESPR) Office of Translational Initiatives and Program Innovationa (OTIPI) Division of Therapeutics and Medical Consequences (DTMC) Division of Neuroscience and Behavior (DNB) Office of Research Training, Diversity, and Disparities |
11:45 p.m. | Break |
Videocast:
Members of the public who may wish to express views regarding any items discussed during this meeting may do so by writing Jeanette Marketon, within ten days of the meeting. Any written statements by members of the public will receive careful consideration.
Join the Videocast.
Open Session
Time | Presentation |
---|---|
1:00 p.m. | Welcome and Opening Remarks Nora Volkow, M.D., Director, NIDA |
1:15 p.m. | Director's Report Nora Volkow, M.D., Director, NIDA |
2:00 p.m. | Discussion Council Members |
2:30 p.m. | National Institute of Drug Abuse Lifetime Achievement Award William L. Dewey, Ph.D. Nora Volkow, M.D., Director, NIDA |
2:45 p.m. | Break |
3:00 p.m. | The Division of Neuroscience and Behavior: Advancing the Neuroscience of Addiction Rita Valentino, Ph.D. Director, Division of Neuroscience and Behavior (DNB) |
3:30 p.m. | Concept Clearances |
4:30 p.m. | Public Comments |
4:45 p.m. | Adjourn |